Korean pharma and bio Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
05:39
Jan 27
Jan 27
Pharma and bio may attract supply.
If auto tariffs cause a market adjustment, KOSDAQ and especially pharma and bio may attract supply as relatively resilient areas.
MED
About Korean pharma and bio Investor Commentary
Across the available history and selected sources, Buzzberg tracks Korean pharma and bio across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Ju-hyeon.